CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home »

ONCOLOGY. Vol. 12 No. 10
The Gerszten/Gerszten Article Reviewed 

Silicone Breast Implants: An Oncologic Perspective

By

Laura J. Esserman, MD, MBA, and James P. Anthony, MD
University of California, San Francisco

| October 1, 1998

The Gerszten and Gerszten review of silicone implants and their impact on cancer patients is quite thorough. It certainly is true that in the majority of patients, silicone implants have little or no adverse affect, particularly with regard to autoimmune disease, cancer detection, and carcino- genesis. However, over the 30-year history of silicone implants, many different types of silicone have been used. The implants differ with regard to manufacturer, fill (some are filled purely with silicone and some with silicone and saline in two different pockets within the implant), shell composition, and thickness, as well as where they are implanted (subglandular or submuscular). These differences may account for some of the variability seen in the data on silicone implants.

Restrictions on the Use of Silicone

Since the 1992 FDA moratorium, the use of silicone implants in the United States has been restricted to women undergoing breast reconstruction after mastectomy and those requiring secondary surgery after breast augmentation. Patients receiving silicone implants must also be included in an ongoing study undertaken by the manufacturer in conjunction with the FDA. Initial breast augmentation procedures must be performed using saline, not silicone, implants.

There is certainly no evidence that silicone exacerbates an existing cancer or causes cancer itself. The initial conclusion is that there is no reason to avoid the use of silicone implants in patients for whom they are deemed necessary. However, one must ask whether silicone implants offer any particular advantage over saline implants. The primary value of silicone implants is that their texture or feel is more natural than that of saline implants. Silicone implants also cause less rippling of the skin, although if immediate reconstruction is performed with skin-sparing mastectomy, the skin shapes more naturally, thus avoiding any rippling.

Problems Associated With Implants

The main reason to avoid the use of silicone implants is that if the implant ruptures, silicone infiltrates the soft tissue and causes an extensive inflammatory reaction with granulation tissue that feels very much like a cancer recurrence. Silicone granules can also travel to the nodes, making them feel hard as well. Finally, such granulation can be difficult to remove (particularly when the majority of the soft tissue is gone), and the removal process may cause damage to the skin. The newer saline and silicone implants have thicker shells and better valves and, thus, should have lower rupture rates.

The issue of capsular contracture poses another significant problem. The authors correctly point out that the degree of a contracture can range from asymptomatic to severe.[1-3] Contractures are also much more common in patients undergoing mastectomy and reconstruction than in those undergoing breast augmentation, as the authors note. The capsular contracture rate may be as high as 30% in mastectomy patients, leading to the issue of the use of autologous tissue rather than an implant for reconstruction.

Autologous Tissue for Reconstruction

Although the initial surgical recovery time may be longer, a transverse rectus abdominus muscle (TRAM) flap can be completed in one stage by an experienced plastic surgeon, a 3- to 5-day hospital stay is required; however, no trips to the office to fill the implant are necessary. In the hands of a good plastic surgeon, TRAM flap reconstruction is extremely reliable, and the cosmetic outcome can nearly always be guaranteed, which is not the case for implants. It is not possible to predict who will have a reasonable outcome and who will have significant contractures that require revisions and capsulectomy.

Furthermore, a careful comparison of the cost of the TRAM flap and implant reconstruction suggests that the TRAM flap is not more expensive in the long term after one factors in all of the follow-up procedures.[3] Lastly, TRAM flap reconstruction is much more natural; it enlarges when the patient gains weight and shrinks when the patient loses weight, therefore preserving symmetry. Most importantly, it does not preclude the option of radiation therapy. If one radiates an implant that does not have autologous tissue on top of it, such as a latissimus flap, it will almost invariably contract significantly, which is painful and disfiguring. If a latissimus flap is used in conjunction with an implant, even if a contracture develops, a capsulectomy can still be performed and the contracture often will not recur.

Strategies forAvoiding Contractures

Patients with long-standing implants tend to develop fewer problems if they undergo breast conservation followed by radiation therapy. However, the authors correctly point out that contractures are a major complication, and although they do not always compromise the cosmetic result, they can be painful and require capsulectomy. Certainly, a patient who undergoes breast conservation and has a poor cosmetic result can still have a tissue-flap reconstruction (either a latissimus or TRAM flap) with a good cosmetic result. Therefore, the patient who would like to avoid a mastectomy could try the simpler procedure, since all patients do not have a poor cosmetic outcome.

Patients with previously existing implants placed submuscularly have fewer contractures than those with implants placed subglandularly. However, the majority of patients who have had implants prior to receiving radiation therapy will require additional surgical procedures, such as capsulectomy and implant exchange, following radiation therapy.

We agree with the authors that, for patients with silicone implants, there is no oncologic reason or indication to remove them unless they produce symptoms or rupture. Patients who develop cancer in the presence of previously placed implants are not precluded from undergoing breast-conservation therapy, but must be aware of the significant likelihood of capsular contracture. Tissue flap reconstruction is an excellent salvage procedure. Given the safety of saline implants, there is no advantage to a silicone over a saline implant. For a patient undergoing mastectomy, silicone implants have a significantly higher rate of contracture than saline implants. Autologous tissue reconstructions avoid these problems.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.



Kristina Gerszten, MD and Peter C. Gerszten, MD, MPH


1. Kroll SS, Evans GR, Reece GP, et al: Comparison of resource costs of free and conventional TRAM flap breast reconstruction. Plast Reconstr Surg 98(1):74-77, 1996.

2. Kroll SS, Evans GR, Reece GP, et al: Comparison of resource costs between implant-based and TRAM flap breast reconstruction. Plast Reconstr Surg 97(2):364-372, 1996.

3. Little G, Baker JL: Results of closed compression capsulotomy for treatment of contracted breast implant capsules. Plast Reconstr Surg 65:30, 1980.


 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
IMAGE IQ

A 48-Year-Old Woman With Irregular Vaginal Bleeding
Brian Morse, MD1 , June 10, 2013

A 48-year-old female presents with complaints of irregular vaginal bleeding and postcoital bleeding. Images from a PET/CT and pelvis MRI reveal characteristic findings. What is your diagnosis?

More Image IQs 

 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • Bladder Cancer Recurrence High, Better Follow-Up Care Needed
  • ASCO: Post-Surgery Surveillance Found Safe in Seminoma
  • Fertility Preservation in Women With Breast Cancer: Challenges and Opportunities
  • Addressing Fertility Concerns in Women Diagnosed With Breast Cancer: Will Serial Reserve Screening Help?
  • Postmenopausal Hormone Receptor–Positive Advanced Breast Cancer
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Preventing Exposure to Hazardous Drugs
  • ASCO: Vinegar Screening Significantly Reduces Cervical Cancer Mortality
  • ASCO: Sulforaphane in Prostate Cancer Found Worthy of Further Investigation
  • Study: Recurrent Heartburn Ups Risk for Throat Cancer
  • HER2-Directed Therapy for Metastatic Breast Cancer
  • Accelerated Partial-Breast Irradiation: The Current State of Our Knowledge
  • It’s Time for Clinicians to Reconsider Their Proscription Against the Use of Soyfoods by Breast Cancer Patients
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • ASCO: No Benefit From Avastin in Newly Diagnosed Glioblastoma
Click here to subscribe to our newsletter



CancerNetwork on Facebook

CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy